Clinical studies in Quebec
Understanding the meaning of clinical studies
Some researchers and physicians dedicate their lives to clinical studies to safely and effectively treat diseases. Clinical studies are essential to develop and test new approaches and treatments for diseases. In addition, for safety purposes, each given drug are rigorously tested through clinical trials before being approved by Health Canada. Through these studies, different approaches are studied:
New medications
Studies on existing treatments
Innovative methods to counter or relieve symptoms
Prevention, detection or, screening studies
Different ways to diagnose diseases
Why do patients volunteer for clinical studies?
The last resort when the patient is faced with an untreatable disease
To improve their current treatment
To contribute to the progress of research
Clinical studies and their main benefits
The main benefits of participating are:
Invaluable access to innovative care
Benefit from new diagnostic tests
Benefit from medical follow-up
Contribute to the progress of research
Clinical studies in Canada
Any drug, therapy, medical device, or health product in Canada is carefully evaluated by clinical studies and a competent regulatory body.
Only if drugs or other health products pass the clinical trial and review process are they allowed to be sold on the market. This is not a simple review, but rather an assessment of :
Safety and security
Efficiency
Quality
However, even if the outcome is favorable and the health product reaches the market, monitoring its effectiveness, safety, and quality is required at all times.
Quebec at the heart of clinical studies
Quebec has positioned itself as a true pioneer in clinical trials. Many elements maintain this status (1):
Some research centers and hospitals are among the best in the world
The universality of the Quebec system that links health care to research allows for a higher level of patient recruitment
Ethnically diverse backgrounds provides real diversity in the conduct of clinical studies in all therapeutic areas
The overall costs of clinical studies in Quebec are the lowest in Canada and all G7 countries
Experts are recognized for their discoveries and expertise in all fields at the international level
More than 20 centers of excellence and more than 30 incubartors
Global players of excellence
A justified repuation
The largest pharmaceutical companies launch more than 5,000 clinical trials annually in Canada. Note that 40% of these trials are done in Quebec (2).
Why is this so? Quebec stands out because of its medical and scientific expertise, infrastructure, and its irreproachable economic and regulatory environment for in-depth research.
In addition, Quebec is also a dynamic and innovative hub in Canada. This situation is perfect for the largest pharmaceutical companies searching for success and technology. Furthermore, Quebec is in the middle of the largest global markets (New York, Boston, and Toronto). It offers low operating costs and a more favorable and advantageous tax regime for any company or investor wishing to set up state-of-the-art research infrastructures.
To learn more, stay tuned to our upcoming blogs or contact us today:
(1) KPMG Competitive Alternatives 2016 / Financial Times fDiBenchmark, 2019
(1) Investissement Québec (investquebec.com)
(2) La Press, Industrie Pharmaceutique et innovation : Le Québec se démarque